Artis BioSolutions is an integrated development and manufacturing company advancing genetic medicines. By combining proprietary synthetic DNA manufacturing with advanced therapy development and GMP manufacturing, Artis provides a connected path from starting material to clinical production. Its enzymatic, cell-free DNA platform, translational expertise, and capabilities across process development, scale-up, and clinical GMP manufacturing help partners reduce complexity, accelerate timelines, and maintain control. With operations in the United States and Europe, Artis supports cell therapy, gene therapy, mRNA, gene editing, vaccines, and other advanced modalities.
Join our mailing list to receive exclusive content and offers.